PU520: Principles of Epidemiology Unit 8 Vaccines and Vaccine-Preventable Diseases Flashcards

1
Q

What are a critical tool in public health and infection prevention, primarily as a primary prevention strategy?

A

Vaccines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do vaccines work?

A

By causing an individual’s system to develop antibodies to either a weakened or dead form of the pathogen. Antibodies are disease specific.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the two forms of immunity?

A

Active and passive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

When does active immunity occur?

A

When the individual is exposed to a pathogen, which triggers the immune system to produce antibodies to that disease.

This type of exposure can occur through infection with the actual disease (which results in natural immunity) or through intentional exposure to a weakened form of the pathogen through vaccination (which results in vaccine-induced immunity). Active immunity, whether naturally occurring or vaccine induced, is long lasting.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What stores the information of the pathogen and where do they reside and how long?

A

Memory B cells, they circulate in the blood and reside in the bone marrow for a long time, if not a lifetime.

Vaccines simulate natural infection and produce a similar immune response, including memory B cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

When does passive immunity occur?

How long does it last?

A

Passive immunity occurs when an individual is given antibodies to a disease, rather than producing them through their own immune system. Neonates have passive immunity from antibodies passed from the mother through the placenta. Passive immunity can also be given by administration of antibody-containing blood products, such as red blood cells, plasma products, and immune globulin.

A third major source of passive immunity is heterologous hyperimmune serum, or antitoxin. It is available for botulism and diphtheria but it carries a risk of inducing an immune reaction to the horse protein, known as serum sickness.

Passive immunity only lasts from a few weeks or months, but the protection is immediate. While active immunity lasts longer, it may take up to several weeks to develop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the different types of vaccines? (4)

A
  • Use of weakened, but live, viruses to generate immunity.
  • Inactivated or killed viruses
  • Inactivated toxins (for bacterial illness where toxins generated by the bacteria are the cause of illness)
  • Segments of the virus (subunit or conjugate vaccines)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are examples of live, attenuated vaccines?

A

Measles, mumps, and rubella (MMR).

Polio vaccine was one as well called OPV or oral polio vaccine. However, it would undergo mutations which was common, so it is no longer used. Now IPV, an inactivated version on the childhood immunization schedule, is used in response. OPV is no longer recommended.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How are live, attenuated vaccines created?

A

A common method to create attenuated vaccine is to grow the virus in a series of chick embryos. With each pass through the chick embryo, the virus adapts at replicating in chick cells, but less able to replicate in human cells. Eventually, the virus will not be able to replicate in human cells at all but the virus will still be recognized by the human immune system. When this weakened virus is given to a human, it cannot replicate to produce illness but can stimulate an immune response that can provide for protection against future infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

T/F Live, attenuated vaccines are fragile to heat and light AND typically provide longer protection than the inactivated version.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How are killed or inactivated vaccines created?

A

Killed, or inactivated, vaccines are created by inactivating the pathogen with heat or chemicals (e.g., formaldehyde or formalin). The heat or chemical treatment destroys the pathogen’s ability to replicate, but the virus is still intact and recognizable by the human’s immune system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the benefit of inactivated vaccines?

A

The benefit of inactivated vaccines is that there is not a risk that they will mutate back to a form that can replicate; however, the immunity provided by these vaccines tends to be shorter acting.

The Centers for Disease Control and Prevention (CDC) says “Inactivated vaccines always require multiple doses.”2(p6) The IPV and the injectable form of the influenza vaccine (IIV) are examples of inactivated vaccines in the recommended childhood immunization schedule.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How are toxoid (antitoxin) vaccines created?

Remember: these are created in response to bacteria that release toxic chemicals that cause disease within the body rather than the presence of the disease itself.

A

For these type of illnesses, an immunization is made by inactivating the toxin by heat or chemical processing, or other methods.3(p2) This type of immunization is called a “toxoid” and is sometimes included under
the category of inactivated/killed vaccines.

Examples of toxoids included in the United States recommended childhood immunization schedule are the tetanus and diphtheria immunizations, which are offered in a combined form.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is a subunit vaccine? Give one example.

What is a recombinant vaccine? Give one example.

A

Other vaccines, such as subunit and conjugate vaccines, only contain pieces of the virus or bacteria that they protect against. Subunit vaccines include only a portion of the pathogen, enough to elicit a response from the human immune system, but not large enough to cause illness. One method of manufacturing subunit vaccines is to isolate a protein from the pathogen and use it as the main antigen.

The acellular pertussis and some versions of the influenza vaccine are made this way.

Another type of subunit vaccines, called recombinant vaccines, can be made through genetic engineering—a gene coding for a vaccine protein (of the target pathogen) is inserted into another virus or into producer cells in culture. The vaccine protein is created when the carrier cell reproduces or when the producer cell metabolizes. When this type of vaccine is given, the immune system will recognize the protein of the target pathogen.

Currently, the only type of recombinant vaccine licensed for use in the United States is the hepatitis B vaccine. HPV as well.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is a polysaccharide vaccine?

A

Polysaccharide vaccines are a type of subunit vaccine that contains a portion of the surface capsule (or coating) of certain bacteria. The long chains of sugar molecules that compose the bacterial coating are used to elicit an immune response.

According to the CDC, Pure polysaccharide vaccines are available for three diseases: pneumococcal disease, meningococcal disease, and Salmonella typhi.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Why is the immune response to a polysaccharide vaccine different than other vaccines?

What age group is this method not recommended for?

A

The immune response to this type of vaccine is typically different in that the B cells can be stimulated without helper T cells.

Unfortunately, this type of immune response is not consistent in children less than 2 years of age, so polysaccharide vaccines are considered ineffective in this age group.

Response to polysaccharide vaccines is also unique in that repeat doses of vaccine do not typically result in increases in antibody levels.

17
Q

Since repeat doses of a polysaccharide vaccine does not increase antibody levels, what was created to address this issue?

A

Conjugation.

This technique entails chemically combining the polysaccharide with a protein molecule. The presence of the protein molecule changes the immune response to a T cell–dependent mechanism, with resulting increased immunogenicity in infants and antibody booster response to multiple doses of vaccine.

The first conjugated polysaccharide vaccine was for Haemophilus influenzae type b (Hib), followed by a conjugate vaccine for pneumococcal disease and a meningococcal conjugate vaccine.

17
Q

What is one of the biggest challenges about using vaccines in less than optimal settings?

A

Proper storage and handling.

Failure to meet best practices for storage and handling can reduce the efficacy of the vaccine and result in a less than optimal immune response in the patient.

There are storage and handling procedures for specific vaccines based on recommendations from manufacturer, but also best practices established for overall vaccine policies.

18
Q

What do many recommendations for storage and handling focus on when it comes to vaccines?

A

Establishing and maintaining a vaccine cold chain.

The vaccine cold chain is a “temperature controlled environment used to maintain and distribute vaccines in optimal condition” and consists of well-trained personnel, reliable transportation and storage equipment, and efficient management procedures.

The cold chain begins at the plant where the vaccine is manufactured, extends through delivery and storage, and ends when the vaccine is given to the patient

19
Q

T/F Vaccine potency can be affected by exposure to extreme heat, cold, or light.

A

True

Once damaged, the vaccine cannot be restored to its full efficacy. Each exposure can further damage the vaccine, leading to a cumulative effect that could result in vaccine failure.

Some vaccines will have visible evidence, such as precipitate or cloudiness, that potency has been affected, but many others will have no change in appearance.

20
Q

In addition to handling and storage of vaccines, what should facilities and organizations that provide vaccines should implement?

A

Vaccine management that is in charge of ordering, managing inventory, and monitoring storage conditions.

There should also be an emergency vaccine retrieval and storage plan for times in which the cold chain might be endangered, such as refrigerator or freezer malfunctions, power failures, or natural disasters.

21
Q

What is the role of the vaccine coordinator?

A

Each facility that offers vaccines should have a primary and alternate vaccine coordinator who is assigned specific responsibilities in order to ensure consistent availability of vaccine and maintenance of the cold chain.

These responsibilities include ordering vaccines and managing vaccine inventory; overseeing proper receipt and storage of deliveries; organizing vaccines within storage unit(s); reading and recording storage unit temperatures a minimum of two times each work day; reading and recording minimum/maximum temperatures once per workday, preferably one time each morning; downloading and reviewing temperature data at least one time each week; rotating stock at least one time each week so that vaccine closest to the expiration date will be used first; removing expired vaccine from storage unit(s); responding to possible temperature excursions; overseeing proper vaccine transport; maintaining all proper documentation; ensuring that staff are adequately trained.

The alternate vaccine coordinator should be familiar with these duties and able to assume these responsibilities if the primary vaccine coordinator is unavailable.

22
Q

What if someone is given an expired vaccine?

A

It should be not counted in the patient’s vaccine history and should be repeated.

23
Q

What should the vaccine

A
23
Q
A